Patents Assigned to Paris-Sud, Universite
  • Use of inhibitors and antisense oligonucleotides of BTK for treating proliferative mastocytosis
    Patent number: 8227433
    Abstract: The present invention relates to a method for treating proliferative mastocytosis comprising administering a Bruton tyrosine kinase (BTK) inhibitor, a BTK antisense to a mammal in need of such treatment. The invention is more particularly suited for treating category II, III and IV mastocytosis.
    Type: Grant
    Filed: May 3, 2004
    Date of Patent: July 24, 2012
    Assignees: Centre National de la Recherche Scientifique (CNRS), Paris-Sud, Universite, Ecole Normale Superieure de Cachan
    Inventors: Christian Auclair, Frédéric Subra